Navigation Links
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
Date:3/8/2010

n aggressive organic growth and further product in-licensing and acquisition."

About EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinase(R) and Kidrolase(R) for the treatment of acute lymphoblastic leukemia, Collatamp(R) G, a surgical implant impregnated with the antibiotic gentamicin, ProstaScint(R) for imaging the extent and spread of prostate cancer and Quadramet(R) for the treatment of pain in patients whose cancer has spread to the bones. EUSA also has several products in late-stage development.

Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, TVM Capital, NeoMed and NovaQuest. Since its foundation, the company has raised over $300 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Limited, the French biopharmaceutical company OPi
'/>"/>

SOURCE EUSA Pharma Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. OncoGenex Pharmaceuticals to Webcast Discussion of Financial Results for Fourth Quarter and Fiscal Year 2009
2. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
3. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
4. PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
5. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
6. OncoGenex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
7. APT Pharmaceuticals Completes Enrollment in Phase III for Inhaled Cyclosporine
8. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
9. Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-121 and Tarceva in Patients with Non-Small Cell Lung Cancer
10. The MedZilla Report for February 2010 - Health Care Growth Slows; Big Pharma May Cut Thousands as Sales Landscape Changes
11. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Albany, New York (PRWEB) September 23, 2014 ... advocates from around the globe will convene ... 11th International Conference, to be held October ... latest in evidence-based research and practice in ... includes physicians, scientists, researchers, nurses, psychologists, nutritionists, ...
(Date:9/23/2014)... CAMBRIDGE, England , September 23, 2014 /PRNewswire/ ... UK launched with funding from Imperial Innovations, Cambridge Innovation ... Inivata, a clinical cancer genomics company focused ... (ctDNA) analysis to improve cancer testing and treatment, ... funding round led by Imperial Innovations and including ...
(Date:9/22/2014)... September 22, 2014 Pearl's Premium Ultra ... in drought tolerant grass seed this week with the ... The announcement coincides with the fact that it is ... as many believe. , As of the date ... favorable reviews by industry experts and the media including: ...
(Date:9/22/2014)... 22, 2014 Research and ... of the "Global Biotechnology Reagents Market 2014-2018" ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Biotechnology reagents are chemical ... system to detect and examine another substance to ... in laboratories to prepare, collect, and examine specimens ...
Breaking Biology Technology:International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4Pearl's Premium Ultra Low Maintenance Lawn Seed Announces A Major Breakthrough In Drought Tolerant Grass Seed 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3
... , , ... ("China Pharma") (NYSE Amex: CPHI ), which develops,manufactures, and ... present at the Brean Murray, Carret & Co. 2009 China,Growth ... Broadway,hotel in New York. Management is scheduled to present ...
... , CRACKS AMAZON.COM BEST SELLER LIST IN SCIENCE ... top ten best selling science books , SEATTLE, Nov. 17 ... new book about the controversial theory of intelligent design made Amazon.com,s ... as the world marks 150 years since Charles Darwin published his ...
... , KVISTGARD, ... today that BARDA (Biomedical Advanced Research and,Development Authority) has ... of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine,with ... The contract provides funds to ...
Cached Biology Technology:China Pharma Holdings, Inc. to Present at Brean Murray China Growth Conference 2Intelligent Design Book Delivers Blow to Darwin 2US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine 2US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine 3
(Date:9/23/2014)... NJ. September 23, 2014. Kessler Foundation scientists have ... foot drop stimulator during a task-specific movement for ... finding indicates that applying the foot drop stimulator ... common complication of stroke. "EMG of the tibialis ... a foot drop stimulator," was published online ahead ...
(Date:9/23/2014)... identified a gene mutation that causes aplastic anemia, ... marrow fails to produce normal amounts of blood ... had blood disorders, the researchers discovered a defect ... with crucial roles in normal cell function. , ... molecular-based treatments that bypass the gene defect and ...
(Date:9/23/2014)... for your mental as your physical health, new research ... Warwick,s Medical School using data from the Health Survey ... focused on mental wellbeing and found that high and ... fruit and vegetable consumption. , 33.5% of respondents with ... fruit and vegetables a day, compared with only 6.8% ...
Breaking Biology News(10 mins):Gene mutation discovered in blood disorder 2Eating five a day may keep the blues away 2
... is allowing scientists to better understand the movement of cells ... microenvironment. In a recent article published in Disease Models ... colleagues used optimized methods of laser microscopy to track the ... cancer. As a tumor grows, it triggers ...
... Activity in Identity ... Management and Biometrics, FALLS CHURCH, Va., Sept. ... relocating the CSC Identity Labs headquarters from Camp,Hill, Pa., to Fairmont, ... alignment with the federal government,s presence in the,I-79 High Technology Corridor, ...
... FL (September 16, 2008)- A team of scientists headed by neuroscientist ... grant by the National Institute of Health (NIH), to develop a ... injury. Dr. Chiba, a professor at the University of Miami,s Department ... groundbreaking process to enhance synapse formation or nerve regeneration., ...
Cached Biology News:CSC Identity Labs Headquarters Relocates to West Virginia 2CSC Identity Labs Headquarters Relocates to West Virginia 3NIH EUREKA grant awarded to University of Miami scientist 2
... AmpliTaq DNA Polymerase is the most thoroughly ... a testimony to its overall utility and ... it ideal for PCR applications. , ... results. ,, AmpliTaq DNA Polymerase is ...
... DNA Polymerase is a versatile and easy-to ... PCR applications. GCpro Taq DNA Polymerase is ... E. coli, containing the DNA polymerase I ... a highly processive 5'-3' DNA polymerase activity. ...
Taq DNA Polymerase (cloned), 250 units. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Polymerases....
APO(a) EIA Sample Size: 25 l...
Biology Products: